Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

Scientists have developed Rhobo6, a light microscopy probe that reveals extracellular matrix structures in live tissues, ...

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body’s immune response ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic cancer cells.

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies.

Pancreatic cancer can cause back pain that spreads from the abdomen. It often affects the middle of the back and may feel like a dull ache. For some people, the pain may come and go. Pancreatic ...